Marvel Biosciences Corp. (MBCOF) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Marvel Biosciences Corp. (MBCOF).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $0.106

Daily Change: +$0.0088 / 8.28%

Range: $0.106 - $0.106

Market Cap: $4,742,868

Volume: 4,000

Performance Metrics

1 Week: 23.57%

1 Month: 92.31%

3 Months: 2.48%

6 Months: 36.55%

1 Year: 18.25%

YTD: -11.96%

Details

Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety, ADHD, non-neurological conditions of cancer, and non-alcoholic steatohepatitis. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.

Selected stocks

SulNOx Group Plc (SNOXF)

Marlowe PLC (MRLWF)

WISE PLC (WPLCF)